116 related articles for article (PubMed ID: 1327503)
1. Adoptive transfer of V beta 2-deleting activity with host cells from mice implanted with C4 preneoplastic hyperplastic alveolar nodules.
Wei WZ; Wang H; Ficsor-Jacobs R; Pauley R
Cancer Res; 1992 Oct; 52(19):5183-9. PubMed ID: 1327503
[TBL] [Abstract][Full Text] [Related]
2. Elimination of V beta 2 bearing T-cells in BALB/c mice implanted with syngeneic preneoplastic and neoplastic mammary lesions.
Wei WZ; Ficsor-Jacobs R; Tsai SJ; Pauley R
Cancer Res; 1991 Jun; 51(12):3331-3. PubMed ID: 2040009
[TBL] [Abstract][Full Text] [Related]
3. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
4. Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice.
Wang H; Gill RF; Lichlyter D; Iglesias A; Bluethmann H; Wei WZ
Eur J Immunol; 1994 Dec; 24(12):2950-6. PubMed ID: 7805721
[TBL] [Abstract][Full Text] [Related]
5. A new infectious mammary tumor virus in the milk of mice implanted with C4 hyperplastic alveolar nodules.
Shakhov AN; Wang H; Acha-Orbea H; Pauley RJ; Wei WZ
Eur J Immunol; 1993 Nov; 23(11):2765-9. PubMed ID: 8223852
[TBL] [Abstract][Full Text] [Related]
6. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
[TBL] [Abstract][Full Text] [Related]
7. Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
Tsai SJ; Loeffler DA; Heppner GH
Cancer Res; 1992 Apr; 52(8):2209-15. PubMed ID: 1559224
[TBL] [Abstract][Full Text] [Related]
8. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A
Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042
[TBL] [Abstract][Full Text] [Related]
9. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus.
Tucek CL; Desaymard C; Papiernik M
J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
Foo-Phillips M; Kozak CA; Principato MA; Abe R
J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
[TBL] [Abstract][Full Text] [Related]
11. The induction of peripheral tolerance by the chronic activation and deletion of CD4+V beta 5+ cells.
Fink PJ; Fang CA; Turk GL
J Immunol; 1994 May; 152(9):4270-81. PubMed ID: 7908916
[TBL] [Abstract][Full Text] [Related]
12. Dramatic hyperplasia of mtv-2+ lymph node grafts in mtv-2- recipients and selective stimulation of V beta 14+ T cells in recipients' lymph nodes in the DDD mouse.
Matsuzawa A; Nakano H; Sakamoto S; Yoshimoto T; Nariuchi H
J Immunol; 1995 Feb; 154(4):1644-52. PubMed ID: 7836749
[TBL] [Abstract][Full Text] [Related]
13. "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants.
Kataoka M; Margenthaler JA; Ku G; Eilers M; Flye MW
Surgery; 2003 Aug; 134(2):227-34. PubMed ID: 12947322
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors.
Korbelik M; Dougherty GJ
Cancer Res; 1999 Apr; 59(8):1941-6. PubMed ID: 10213504
[TBL] [Abstract][Full Text] [Related]
15. Pertussis toxin interferes with superantigen-induced deletion of peripheral T cells without affecting T cell activation in vivo. Inhibition of deletion and associated programmed cell death depends on ADP-ribosyltransferase activity.
Gonzalo JA; González-García A; Baixeras E; Zamzami N; Tarazona R; Rappuoli R; Martínez C; Kroemer G; Tarazona R; Terezone R
J Immunol; 1994 May; 152(9):4291-9. PubMed ID: 7908917
[TBL] [Abstract][Full Text] [Related]
16. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
[TBL] [Abstract][Full Text] [Related]
17. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
18. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
19. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
Modlin CS; Todd GT; Cohen TD; Fairchild RL
Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the adoptive transfer of delayed hypersensitivity and T cell repertoire in severe combined immunodeficiency mice reconstituted with human lymphocytes.
Mancia L; Mariani F; Mattei M; Montesano C; Placido R; Colizzi V; Salerno A; Bellavia A
Folia Biol (Praha); 1994; 40(6):411-30. PubMed ID: 7589700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
